|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosch FX, Ribes J, Diaz M and Cléries R:
Primary liver cancer: Worldwide incidence and trends.
Gastroenterology. 127(5 Suppl 1): S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turdean S, Gurzu S, Turcu M, Voidazan S
and Sin A: Current data in clinicopathological characteristics of
primary hepatic tumors. Rom J Morphol Embryol. 53(Suppl 3):
719–724. 2012.PubMed/NCBI
|
|
4
|
Severi T, van Malenstein H, Verslype C and
van Pelt JF: Tumor initiation and progression in hepatocellular
carcinoma: Risk factors, classification and therapeutic targets.
Acta pharmacol Sin. 31:1409–1420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang ZY: Hepatocellular carcinoma
surgery-review of the past and prospects for the 21st century. J
Surg Oncol. 91:95–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De
Xiang B, Peng T, Han ZG and Li LQ: The p53 mutation spectrum in
hepatocellular carcinoma from Guangxi, China: Role of chronic
hepatitis B virus infection and aflatoxin B1 exposure. Liver Int.
35:999–1009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye H, Zhang C, Wang BJ, Tan XH, Zhang WP,
Teng Y and Yang X: Synergistic function of Kras mutation and HBx in
initiation and progression of hepatocellular carcinoma in mice.
Oncogene. 33:5133–5138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Gao JZ, Du JL and Wei LX: Prognostic
and clinicopathological significance of glypican-3 overexpression
in hepatocellular carcinoma: A meta-analysis. World J
Gastroenterol. 20:6336–6344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Q, Wang R, Wang Y, et al: Notch1 is a
potential therapeutic target for the treatment of human hepatitis B
virus X protein-associated hepatocellular carcinoma. Oncol Rep.
31:933–939. 2014.PubMed/NCBI
|
|
10
|
Zhang CH, Xu GL, Jia WD, Ge YS, Li JS, Ma
JL and Ren WH: Prognostic significance of osteopontin in
hepatocellular carcinoma: A meta-analysis. Int J Cancer.
130:2685–2692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie L, Jiang H and Wu F: Role of
Wnt/β-catenin signaling pathway in promoting tumorigenesis of
hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao.
34:913–917. 2014.(In Chinese). PubMed/NCBI
|
|
12
|
Janku F, Kaseb AO, Tsimberidou AM, Wolff
RA and Kurzrock R: Identification of novel therapeutic targets in
the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using
targeted next generation sequencing. Oncotarget. 5:3012–3022. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54:301, 303–304. 2013.
|
|
14
|
Kapranov P, Cheng J, Dike S, Nix DA,
Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J,
Hofacker IL, et al: RNA maps reveal new RNA classes and a possible
function for pervasive transcription. Science. 316:1484–1488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koerner MV, Pauler FM, Huang R and Barlow
DP: The function of non-coding RNAs in genomic imprinting.
Development. 136:1771–1783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Costanzi C and Pehrson JR: Histone
macroH2A1 is concentrated in the inactive X chromosome of female
mammals. Nature. 393:599–601. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reis EM, Nakaya HI, Louro R, Canavez FC,
Flatschart AV, Almeida GT, Egidio CM, Paquola AC, Machado AA, Festa
F, et al: Antisense intronic non-coding RNA levels correlate to the
degree of tumor differentiation in prostate cancer. Oncogene.
23:6684–6692. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu ZH, Wang XL, Tang HM, Jiang T, Chen J,
Lu S, Qiu GQ, Peng ZH and Yan DW: Long non-coding RNA HOTAIR is a
powerful predictor of metastasis and poor prognosis and is
associated with epithelial-mesenchymal transition in colon cancer.
Oncol Rep. 32:395–402. 2014.PubMed/NCBI
|
|
24
|
Huang J, Ke P, Guo L, Wang W, Tan H, Liang
Y and Yao S: Lentivirus-mediated RNA interference targeting the
long noncoding RNA HOTAIR inhibits proliferation and invasion of
endometrial carcinoma cells in vitro and in vivo. Int J Gynecol
Cancer. 24:635–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW,
Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding
RNA HOTAIR predicts poor patient prognosis and promotes tumor
metastasis in epithelial ovarian cancer. Gynecol Oncol.
134:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu TH, Wang CC, Huang CC, Chen CL, Hung
CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS and Tai MH:
Down-regulation of tumor suppressor gene PTEN, overexpression of
p53, plus high proliferating cell nuclear antigen index predict
poor patient outcome of hepatocellular carcinoma after resection.
Oncol Rep. 18:1417–1426. 2007.PubMed/NCBI
|
|
33
|
Niland CN, Merry CR and Khalil AM:
Emerging roles for long non-coding RNAs in cancer and neurological
disorders. Front Genet. 3:252012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Wu Z, Mei Q, Li X, Guo M, Fu X and
Han W: Long non-coding RNA HOTAIR, a driver of malignancy, predicts
negative prognosis and exhibits oncogenic activity in oesophageal
squamous cell carcinoma. Br J Cancer. 109:2266–2278. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gupta RA, Shah N, Wang KC, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses
epithelial-mesenchymal transition in gastric cancer. Int J Biol
Sci. 9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY,
Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, a prognostic factor in
esophageal squamous cell carcinoma, inhibits WIF-1 expression and
activates Wnt pathway. Cancer Sci. 104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qu B, Liu BR, Du YJ, Chen J, Cheng YQ, Xu
W and Wang XH: Wnt/β-catenin signaling pathway may regulate the
expression of angiogenic growth factors in hepatocellular
carcinoma. Oncol Lett. 7:1175–1178. 2014.PubMed/NCBI
|
|
41
|
Dahmani R, Just PA and Perret C: The
Wnt/β-catenin pathway as a therapeutic target in human
hepatocellular carcinoma. Clin Res Hepatol Gastroenterol.
35:709–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
